ABHD11 and gastric cancer: ABHD11-AS1 sponges miR-361-3p [18], miR-1231 [26], and miR-330-5p [36] to exhibit oncogenic effects via targeting PDPK1, CCNE1 (cyclin E1), and MARK2 in GC, PC, and CC, respectively.